Our results suggest that miR-137 may serve as a biomarker in GBM, and the modulation of itsm activity may represent a novel therapeutic strategy for the treatment of GBM patients.
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback